Egyptian Program to Study and Treat Hypertrophic Cardiomyopathy Including Patient-Specific Medical and Surgical Care

What this Trial Is About

Researchers are conducting the Egyptian Hypertrophic Cardiomyopathy HCM Program to understand the incidence, severity, and characteristics of HCM in Egypt. The study also aims to explore genetic factors and the underlying molecular and cellular mechanisms that influence the diseases different forms. A key focus is on patients who have genetic markers but no symptoms, which may provide insight into how the disease develops. The program involves detailed characterization of patients and their relatives through clinical, genetic, and laboratory assessments. It includes training for Egyptian medical professionals in advanced diagnostic and treatment techniques. The study uses state-of-the-art medical, surgical, and interventional methods tailored to each patients condition, with ongoing collection and analysis of human tissue samples from surgical procedures. Participants will undergo regular follow-ups approximately once per year, over an average of five years, to monitor disease progression and severity through clinical exams, imaging, and genetic testing. The study measures include the incidence of HCM, clinical severity, cardiac phenotype, and genotype correlations. This long-term observation aims to improve understanding and management of HCM in Egypt while supporting advanced training and research development.

Egyptian Hypertrophic Cardiomyopathy Program